...terone Receptor (PR) Competitor Assay Kits are ide...ceptor binding compounds using fluorescence polari...n of glutathione transferase to the ligand binding...)] and a proprietary, fluorescently tagged progest...
Organic Acid Analysis Standard, 6 vials from Bio-Rad
...anys Molecular Imaging Systems group announces the...Imaging Systems, featuring high resolution cooled ...ce, luminescence, radiographic and chromogenic ima...nd 10x optical zoom lens provides spatial resoluti...
...particle shape and size analyzer offering a wide d... simplicity in mind. It is comprised of a chemical...l bench. The system is completely computer control...r different applications such as dry or where smal...
Biology Products:(Date:12/2/2009)..., , SHANGHAI, Dec. 2 /PRNewswire-Asia...s; markets are in turmoil and uncertainty is part ...at the pharma industry has been,relatively immune ...take a,vacation. , During the midst of th...ant Johnson & Johnson inaugurated an R&D c...
(Date:12/1/2009)..., , INCLINE VILLAGE, Nev., Dec. 1 /PRNewswire... PDLI ) today announced revenue guidance for the f...tely $57 million, as compared with $69 million for...arter 2008 results was the first of two installmen...cluded in fourth quarter 2008 results was a one-ti...
(Date:12/1/2009)..., , PLYMOUTH, Mass., Dec. 1 ... announced today results from the company sponsore...handra Medical Center in Chennai, India using the ...econstructable Critical Limb Ischemia (CLI). Sri R...ernational-associated institution based in Chennai...
(Date:12/1/2009)..., , SARASOTA, Fla., Dec. 1 ...ts, Osprey Biotechnics Inc. of Sarasota has appoin...stributor. ,, Lake is located near Birmingham,...cial bacteria which serve the agricultural, waste ... bred to be hungry and to open drain fields, and c...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3